Quest Diagnostics DGX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Quest Diagnostics’s reported figures.
Based on the most recent quarter.
The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quest Diagnostics's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Quest Diagnostics's cash ratio?
- Quest Diagnostics (DGX) reported cash ratio of 0.2× in Q1 2026.
- How has Quest Diagnostics's cash ratio changed year-over-year?
- Quest Diagnostics's cash ratio increased by 38.3% year-over-year, from 0.1× to 0.2×.
- What is the long-term trend for Quest Diagnostics's cash ratio?
- Over 4 years (2021 to 2025), Quest Diagnostics's cash ratio has grown at a -25.1% compound annual growth rate (CAGR), from 2.1× to 0.7×.
- What does cash ratio mean?
- How much of its short-term bills the company could pay with cash on hand right now.
- How do you interpret cash ratio?
- A buffer against stress, but persistently high cash ratios can indicate under-deployed capital. Interpret alongside the company's capital-allocation strategy.
- How does cash ratio compare across companies?
- Varies widely by business model and treasury policy; best read against the company's own history.